sodium arsenite has been researched along with Hyperplasia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, LL; Cohen, SM; Kakiuchi-Kiyota, S; Pennington, KL; Suzuki, S | 1 |
| Adair, B; Ahlborn, GJ; Allen, JW; Delker, DA; Diwan, BA; Grindstaff, RD; Hernandez-Zavala, A; Kitchin, KT; Nelson, GM; Preston, RJ; Thomas, DJ; Waalkes, MP | 1 |
| Bowen, BP; Brophy, CM; Flynn, CR; Komalavilas, P; Lopes, LB; Panitch, A; Seal, B; Smoke, C; Yi, Z | 1 |
| Dong, JT; Luo, XM; Zhou, CN | 1 |
| Ding, M; Harki, D; Kayama, F; Kommineni, V; Luster, MI; Matheson, J; Simeonova, PP; Toriuma, W; Unimye, N; Vallyathan, V; Wang, S | 1 |
5 other study(ies) available for sodium arsenite and Hyperplasia
| Article | Year |
|---|---|
Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetophenones; Acetylcysteine; Animals; Antioxidants; Arsenites; Ascorbic Acid; Cacodylic Acid; Carcinogens; Cell Line; Cell Proliferation; Cytoprotection; Deoxyguanosine; Diet; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hyperplasia; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred F344; Sodium Compounds; Urinary Bladder; Urothelium | 2009 |
Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice.
Topics: Administration, Oral; Adrenal Gland Neoplasms; Animals; Arsenites; Carcinogens; Drug Administration Schedule; Female; Hyperplasia; Liver Neoplasms; Male; Maternal Exposure; Maternal-Fetal Exchange; Mice; Mice, Inbred C3H; Oviducts; Pregnancy; Prenatal Exposure Delayed Effects; Sodium Compounds; Time Factors; Urinary Bladder; Water Supply | 2009 |
A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model.
Topics: Animals; Aorta; Arsenites; Cell Movement; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Enzyme Inhibitors; Fibronectins; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Hyperplasia; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Microscopy, Confocal; Molecular Chaperones; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Peptides; Phosphorylation; Protein Array Analysis; Protein Serine-Threonine Kinases; Rats; Saphenous Vein; Sodium Compounds; Tissue Culture Techniques; Tunica Intima | 2010 |
Induction of preneoplastic lesions by sodium arsenite in human fetal respiratory epithelia in organ culture.
Topics: Arsenites; Bronchi; Epithelium; Fetus; Humans; Hyperplasia; Lung; Lung Neoplasms; Methylnitronitrosoguanidine; Organ Culture Techniques; Precancerous Conditions; Sodium Compounds; Trachea; Tracheal Neoplasms | 1995 |
Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation.
Topics: Animals; Arsenates; Arsenites; CCAAT-Enhancer-Binding Proteins; Cell Division; Crosses, Genetic; DNA Damage; DNA-Binding Proteins; Early Growth Response Protein 1; Female; GADD45 Proteins; Gene Expression Regulation; Genes, fos; Genes, jun; Humans; Hyperplasia; Immediate-Early Proteins; Intracellular Signaling Peptides and Proteins; Luciferases; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Proteins; Sodium Compounds; Tetradecanoylphorbol Acetate; Tissue Distribution; Transcription Factor AP-1; Transcription Factor CHOP; Transcription Factors; Transcriptional Activation; Urinary Bladder; Urothelium | 2000 |